在治疗与物质使用障碍并发症的饮食障碍方面,新的潜在药理学方法
1Addiction Biology Unit, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA.
概括
饮食障碍 (ED) 和物质使用障碍 (SUD) 经常因共同的神经生物学和心理特征而同时发生. 针对这些重叠的新药疗法显示出治疗这些复杂疾病的前景.
科学领域:
- 神经科学和精神病学 在
- 药理学 药理学是指药理学的学科.
- 成 药物 药物 药物 药物
背景情况:
- 饮食障碍 (ED),包括神经性厌食症 (AN),神经性食欲 (BN) 和过度饮食障碍 (BED),影响20-30%的物质使用障碍 (SUD) 患者.
- 共享的神经生物学途径 (多巴胺,阿片类,大麻素系统) 和心理因素 (冲动性,焦虑,压力) 驱动这种并发症.
- 由于缺乏FDA批准的治疗方法,用于同时发生的ED和SUD,因此需要创新的治疗策略.
研究的目的:
- 审查主要ED和SUD的流行病学,神经生物学和行为共同点.
- 检查ED与SUD并发症的药物治疗中的最新进展.
- 突出整合治疗方法的潜在未来研究方向.
主要方法:
- 对流行病学数据,神经生物学机制和共患性ED和SUD的药理干预措施的文献综述.
- 对针对重叠的神经通路和行为的药物治疗现有研究的分析.
- 探索新兴治疗方法,包括荷尔蒙药物和特定化合物.
主要成果:
- 有前途的药物治疗包括对强迫性行为和情绪的奥兰扎宾和胺,以及对狂欢和渴望的GLP-1受体激动剂.
- 荷尔蒙药物 (莱普丁,格林,催产素) 和诸如β-卡里奥菲伦和利斯德美胺之类的化合物显示出对特定ED/SUD症状的潜在影响.
- 综合的药物治疗和心理方法对于有效的治疗至关重要.
结论:
- 针对共享的神经生物学途径的药物治疗为治疗同时发生的ED和SUD提供了新的希望.
- 基于遗传和神经生物学资料的个性化医疗对于优化治疗结果至关重要.
- 未来的研究应该专注于大规模的临床试验和综合治疗模式,以改善恢复和长期健康.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
373
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
373
Binge Eating Disorders
184
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
184
Bulimia Nervosa
200
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
200
Drug Abuse and Addiction: Pharmacological Phenomena
659
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
659
Substance Use Disorders Affecting Sleep
225
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
225
Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107


